Ruishan Zhang Selected Research

Estrogen Receptors

1/2020	EZH2 inhibitors-mediated epigenetic reactivation of FOSB inhibits triple-negative breast cancer progress.
3/2010	Clinical implications for nestin protein expression in breast cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ruishan Zhang Research Topics

Disease

6	Breast Neoplasms (Breast Cancer) 01/2023 - 03/2010
3	Triple Negative Breast Neoplasms 01/2020 - 03/2010
3	Neoplasms (Cancer) 05/2012 - 12/2008
2	Neoplasm Metastasis (Metastasis) 09/2012 - 03/2010
2	Lymphatic Metastasis 05/2012 - 03/2010
2	Stomach Neoplasms (Stomach Cancer) 03/2010 - 12/2008
1	Hypertensive Intracranial Hemorrhage 02/2024

Drug/Important Bio-Agent (IBA)

2	Estrogen ReceptorsIBA 01/2020 - 03/2010
2	human ERBB2 proteinIBA 01/2020 - 03/2010
2	Progesterone Receptors (Progesterone Receptor)IBA 01/2020 - 03/2010
2	NestinIBA 05/2012 - 03/2010
1	Therapeutic UsesIBA 02/2024
1	LipocalinsIBA 01/2023
1	Biomarkers (Surrogate Marker)IBA 09/2012
1	Proteins (Proteins, Gene)FDA Link 09/2012
1	Staphylococcal Protein A (Protein A)IBA 09/2012
1	ParaffinIBA 05/2012

Therapy/Procedure

2	Gastrectomy 03/2010 - 12/2008
1	Drug Therapy (Chemotherapy) 03/2017
1	Mastectomy (Mammectomy) 03/2010
1	Adjuvant Chemotherapy 12/2008